Affects half of all octogernarians
and is diagnosed in 3 in 1,000 newborns.
Rescue Hearing Inc. Announces Addition of Business Advisor Andrew Koopman
Rescue Hearing Inc. Announces Addition of Drug Development Advisor Dr. Lee Golden
Meet our Medical Specialists
DR. HINRICH STAECKER MD, PHD
DR. ZHENG-YI CHEN, D. PHIL.
DR. XUE ZHONG LIU, MD, PHD, FACS
Rescue Hearing Inc. is excited to welcome our new scientist Dr. Anthanasia Warnecke to its Scientific Advisory Board
GAINESVILLE- December 8th, 2021- Rescue Hearing Inc is excited to welcome our new scientist, Dr. Anthanasia Warnecke, to its Scientific Advisory Board. Dr. Warnecke is a
RHI set to Present groundbreaking POC data at the Annual MidWindter Meeting (2/24) for the Association for Research in Otolaryngology(ARO)
Gene Therapy to Treat Mouse Model of Human Recessive Deafness Caused by a TMPRSS3 Mutation (ABSRTRACT) Annual MidWinter Meeting Background: Expected to afflict every one
We want to congratulate our very own Dr. Jeff Holt for winning the 2021 ARO Virtual MidWinter Meeting Pioneer Award in Basic Science. This is
for any inquiries
Request an appointment
RHI has produced positive proof of concept data on the first of its 3 gene therapy assets, RHI100
A multi $B asset (Peak revenue 2032)
Entering IND enabling studies phase
Worldwide patent protection through 2041
RHI CSO Dr. Hinrich Staecker is the pioneer of gene therapy for hearing loss as the PI and inventor of the only gene therapy for hearing loss approved for human clinical trial (CGF-166 Novartis).